Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Return on Capital Employed: 2024-2025

  • Abivax's Return on Capital Employed was N/A to -4.95% in Q2 2025 from the same period last year, while for Jun 2025 it was -4.95%, marking a year-over-year change of. This contributed to the annual value of -1.00% for FY2024, which is 16.00% up from last year.
  • According to the latest figures from Q2 2025, Abivax's Return on Capital Employed is -4.95%, which was down 213.45% from -1.58% recorded in Q1 2025.
  • Over the past 5 years, Abivax's Return on Capital Employed peaked at -0.53% during Q4 2024, and registered a low of -4.95% during Q2 2025.
  • Its 2-year average for Return on Capital Employed is -2.35%, with a median of -1.58% in 2025.